500 mg/2 ml powder and solvent for solution for injection for intramuscular use
1 g/3,5 ml powder and solvent for solution for injection for intramuscular use
500 mg/5 ml powder and solvent for solution for injection for intravenous use
1 g/10 ml powder and solvent for solution for injection for intravenous use
2 g powder for solution for infusion
J01DD04 -antibacterials for systemic use, third-generation cephalosporins
PANTOXON is indicated for the treatment of the following infections in adults and children including term neonates (from birth):
Community Acquired pneumonia
Hospital Acquired pneumonia
Acute otitis media
Complicated urinary tract infections (including pyelonephritis)
Infections of bones and joints
Complicated skin and soft tissue infections
PANTOXON may be used:
For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults.
For treatment of disseminated Lyme borreliosis (early [stage II] and late [stage III]) in adults and children including neonates from 15 days of age.
For Pre-operative prophylaxis of surgical site infections.
In the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above
Summary of Product Characteristics - Pantoxon - 500 mg/2 ml_1 g/3,5 ml